|
|
Article: Panel: Confess About Failures, Then Push Research Onward.
- Article from:
- BIOWORLD Today
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Staff Writer
TORONTO - "Delusional."
That's the word drug development consultant Anthony Fox used Wednesday at the Biotechnology Industry Organization's International Biotechnology Convention & Exhibition to describe some CEOs who allow failing drugs to move through the clinic.
He's heard all the spins, all the excuses, such as, "We're small and the FDA won't make us do all the things that the big boys must do." Or, "Of course it's got proof of concept. It worked fine in my mother-in-law/dog/VP of chemistry." Or, "The drug works, although we failed to reach our endpoint because the placebo response rate was unexpectedly high."
"Why ...